Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion
- Conditions
- Sacroiliac Joint DysfunctionSacroiliac; Fusion
- Registration Number
- NCT06487936
- Lead Sponsor
- CornerLoc
- Brief Summary
This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 120
- Age 18 year or older
- Confirmed Implant of the Transloc 3D Fusion System
- Did not have Transloc device removed or another manufacturer device implanted post Transloc
- Does not have other manufacturer's titanium or metal implant
- Patient may be included with prior allograft implant
- Willing to participate and give written consent
- Must have or planned CT post ≥1 year per standard of care
- Patient is younger than 18 years
- Patient is unable to sign the Informed Consent
- Implant of other manufacturer's titanium or alternative metal implant
- Revision with another manufacturer's implant
- Fracture or unresolved trauma of implant side after implantation of TransLoc
- Patient unwilling to participate in Patient Satisfaction Survey
- Patient has not returned for Standard of Care follow-up
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient Satisfaction Survey Prospective 12 to 18 months post surgery Patient satisfaction survey administered greater than 1 year post-op: satisfaction, functional improvement, and disability as it relates to their SI joint
- Secondary Outcome Measures
Name Time Method Visual Analogue Scale (VAS) of pain Baseline up to 1 year post surgery Retrospective analysis of VAS pre and post surgery, if available
Oswestry Disability Index (ODI) Baseline up to 1 year post surgery Retrospective analysis of ODI pre and post surgery, if available
CT Scan Second Read (Radiological Overread) 12 to 18 months post fusion surgery CT scan for placement and fusion
SAEs Time of surgery up to 90 days post surgery Retrospective capture of Serious Adverse Events (SAEs) from the time of SI Fusion up to 90 days post operatively that required re-operation or in-patient hospitalization.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Advanced Orthopedic Center
🇺🇸Port Charlotte, Florida, United States
Advanced Orthopedic Center🇺🇸Port Charlotte, Florida, United StatesLee James, DOContact